The global synthetic biology market, by product type (oligonucleotides, enzymes, cloning and assembly kits, xenonucleic acids (XNA) and chassis organism), by technology (gene synthesis, next-generation sequencing, cloning and sequencing, bioinformatics, microfluidics, nanotechnology, site saturation mutagenesis and mathematical modelling), by application (medical applications (drug discovery and therapeutics and artificial tissues and tissue regeneration), industrial applications (biomaterials and green chemicals, industrial enzymes and biofuels and renewable energy), and Environmental applications (bioremediation and whole-cell biosensors)) and by region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) were valued at 6.0 billion US Dollars in 2021 and is expected to grow at a CAGR of 33.9% over the forecast period (2022 – 2028).

Get Free Sample PDF Copy (Including Full Table of Contents, List of Tables and Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/112

Key players are involved in adopting inorganic growth strategies such as collaboration and partnership to improve market presence. For example, in April 2018, Twist Bioscience Corporation expanded its presence in Asia Pacific through strategic distribution partners for the commercialization of synthetic DNA, exome and a suite of custom target enrichment products. for next-generation sequencing. These partners include Recenttec KK, DNA Link and its subsidiary LnCBio Inc., Premas Life Sciences and BioArrow Technology Limited. Additionally, in January 2015, AstraZeneca collaborated with Thermo Fisher Scientific. As part of this collaboration, Thermo Fisher has agreed to provide guideline RNA libraries targeting known human genes and gene families. Additionally, in July 2017, Quintara Biosciences partnered with Twist Bioscience to launch two new services: qBlock Gene Fragments and qGene DNA cloning.

Moreover, key companies are focusing on mergers and acquisitions, in order to expand their presence in the market. For example, in April 2018, Danaher Corporation completed the acquisition of Integrated DNA Technologies, Inc. for a value of approximately US$2.1 billion. Integrated DNA Technologies, Inc. (IDT) is a supplier of consumables for genomic applications in molecular biology, quantitative polymerase chain reaction (qPCR), next-generation sequencing (NGS), synthetic biology, editing of genes and molecular diagnostics.

Request a PDF brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/112

Take away key

The global synthetic biology market is expected to grow at a CAGR of 33.9% during the forecast period, driven by increasing research and development funding and rising entry of biology start-ups synthetic in this market.

Based on product type, oligonucleotide segment accounted for major market share in 2017. The demand for oligonucleotides will be propelled during the forecast period, driven by the emergence of several promising concepts to produce oligonucleotides of profitable way. For example, the in situ synthesis of microarrays of oligonucleotides has gained ground because it allows oligo sequences to be generated in a parallel and miniaturized way and offers advantages in terms of throughput and reagent consumption.

Based on technology, the gene synthesis segment accounted for the largest share in 2017. Gene synthesis was used for the development of synthetic biology applications. Reductions in the cost of producing genes and related raw materials such as oligonucleotides are driving demand for synthetic biology products.

Based on applications, medical applications segment accounted for the largest share in 2017. Synthetic biology has various medical applications in cancer treatment, personalized medicine, drug discovery and development, and regenerative medicine. In addition, growing commitment from research universities, government investments and rapidly declining costs of genetic sequencing are supporting the growth of the medical applications segment in the synthetic biology market.

The major players operating in the global synthetic biology market are Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Genscript Biotech Corporation, Codexis, Inc., Amyris, Inc., Danaher Corporation (Integrated DNA Technologies, Inc.), EnBiotix, Inc., Evonetix Ltd., Ginkgo Bioworks, Inc. and Prokarium.

Reasons to Buy this Synthetic Biology Market Report

➡ Save time conducting entry-level research by identifying the size, growth, and key players in the emerging Synthetic Biology Market

➡Use five forces analysis to determine the competitive intensity and hence attractiveness of the emerging synthetic biology market

➡Key Company Profiles Reveal Details of Top Five Synthetic Biology Market Players Emerging Transactions and Financial Performance

➡Add weight to presentations and presentations by understanding the future growth prospects of the emerging synthetic biology market with five-year historical forecasts

➡Compares data from North America, South America, Asia-Pacific, Europe and the Middle East, as well as individual chapters on each region.

𝐁𝐮𝐲 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐎𝐟𝐟 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 𝐎𝐟𝐟 𝐎𝐟𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐎𝐟𝐟 𝐎𝐟𝐟 𝐎𝐟𝐟 𝐎𝐟𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐎𝐟𝐟 𝐎𝐟𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐎𝐟𝐟 𝐎𝐟𝐟 𝐎𝐟𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐑𝐞𝐩𝐨𝐫𝐭
https://www.coherentmarketinsights.com/promo/buynow/112

Contents

Chapter 1 Industry overview
1.1 Definition
1.2 Assumptions
1.3 Scope of research
1.4 Market Analysis by Regions
1.5 Synthetic Biology Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Impact on Synthetic Biology Industry

Chapter 2 Global Synthetic Biology Competition by Types, Applications, and Top Regions and Countries
2.1 Global Synthetic Biology (Volume and Value) by Type
2.3 Global Synthetic Biology (Volume and Value) by Regions

chapter 3 Generation market analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Synthetic Biology Sales, Consumption, Export, Import by Regions
Chapter 5 North America Synthetic Biology Market Analysis
Chapter 6 Analysis of the synthetic biology market in East Asia
Chapter 7 Analysis of the synthetic biology market in Europe
Chapter 8 South Asia Synthetic Biology Market Analysis
Chapter 9 Southeast Asia Synthetic Biology Market Analysis
Chapter 10 Analysis of the synthetic biology market in the Middle East
Chapter 11 Analysis of the synthetic biology market in Africa
Chapter 12 Analysis of the synthetic biology market in Oceania
Chapter 13 Analysis of the synthetic biology market in South America
Chapter 14 Company profiles and key figures of the synthetic biology sector
Chapter 15 Global Synthetic Biology Market Forecast (2021-2028)
Chapter 16 conclusion
Research methodology….

About Us:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We’re known for our actionable insights and genuine reports in a variety of fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leading role in providing insight in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Contact:

Consistent market information
1001 4th Ave, #3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837